- ALXN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $172.3 million.
- ALXN has traded 22,050 shares today.
- ALXN is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ALXN with the Ticky from Trade-Ideas. See the FREE profile for ALXN NOW at Trade-Ideas More details on ALXN: Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. ALXN has a PE ratio of 81.2. Currently there are 13 analysts that rate Alexion Pharmaceuticals a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for Alexion Pharmaceuticals has been 1.1 million shares per day over the past 30 days. Alexion has a market cap of $38.6 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.40 and a short float of 1.8% with 3.30 days to cover. Shares are up 44.9% year-to-date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.